<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 has been implicated in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the regulatory mechanisms underlying aberrant T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 expression in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> have not been well defined </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate the relationship between methylation status and expression levels of T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 gene, methylation-specific polymerase chain reaction, and immunohistochemistry staining were performed in 232 matched samples of human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue and <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa </plain></SENT>
<SENT sid="3" pm="."><plain>Results showed that T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 protein was overexpressed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, especially in metastatic cases (P &lt; .001) </plain></SENT>
<SENT sid="4" pm="."><plain>The degree of T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 promoter methylation was a little lower in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues than in matched <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (P &lt; .05), and the expression level of T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 was inversely related to the methylation status in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues (P &lt; .001) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0003003'>Colon cancer</z:hpo> cell lines HT29 and LS174T were treated with demethylating agent <z:chebi fb="0" ids="50131">5-aza-2'-deoxycytidine</z:chebi>, resulting in promoter hypomethylation accompanied by reexpression of T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 mRNA and protein </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines SW620 and LoVo were treated with hypermethylation agent S-adenosylmethionine, resulting in T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 promoter hypermethylation, accompanied by suppression of T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 expression and inhibition of cell growth, plate colony formation, and migration </plain></SENT>
<SENT sid="7" pm="."><plain>The present study demonstrates that overexpression of T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 is associated with hypomethylation status of T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 promoter region in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues </plain></SENT>
<SENT sid="8" pm="."><plain>It suggests that promotor hypomethylation of T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 may play a role in the progression and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Pharmacologic reversal of T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> 1 promoter hypomethylation may inhibit cell proliferation and migration </plain></SENT>
</text></document>